Kriya Therapeutics launches new division for eye diseases
After a $100 million Series B financing round, Kriya Therapeutics, which has headquarters in Research Triangle Park and Palo Alto, California, is launching a new division focusing…
After a $100 million Series B financing round, Kriya Therapeutics, which has headquarters in Research Triangle Park and Palo Alto, California, is launching a new division focusing…